The Board denied the Veteran's claim for service connection for bilateral Achilles tendon nodules, finding that there was insufficient evidence to establish a link between his current condition and either his active duty or his service-connected testicular cancer.
The deciding factor: The VA examiner did not find a direct relationship between the Veteran's bilateral Achilles tendon nodules and his active duty service, nor could they determine if chemotherapy for his testicular cancer aggravated any pre-existing condition.
- Claimed conditions
- Bilateral Achilles tendon nodules, Testicular cancer
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- February 28, 2018
- Citation
- 1812584
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 1812584.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Board has remanded the case due to errors in pre-decisional duty to assist and other statutory and regulatory duties. The appellant is not provided with proper notice for a cause of death claim, and further development is needed regarding herbicide agent exposure and radiation exposure during service.
- Whole decision: Granted
The Veteran's residuals of testicular and ureter cancer have been rated at 40 percent since June 30, 2022. The decision grants an earlier effective date for this rating.
- Whole decision: Partly granted
The Board granted service connection for posttraumatic stress disorder (PTSD) and remanded the remaining claims for further development.
- Whole decision: Dismissed
The Board dismissed the Veteran's appeals for increased ratings and service connection due to a timely Notice of Disagreement.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.